Stock Market News

Takeda (TAK) Receives FDA Priority Review for Rusfertide in PV Treatment

wcc wcc
Apr 05, 2026 - 00:10
0 4
Takeda (TAK) Receives FDA Priority Review for Rusfertide in PV Treatment
Previous Article

TKO Group (TKO) Announces $1B Share Repurchase Initiative

Next Article

Intel (INTC) to Repurchase 49% Interest in Fab 34 JV for $14.2B

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
wcc
wcc

Related Posts

Why Alnylam’s Best Quarter Ever Didn’t Come With a Richer Valuation

Why Alnylam’s Best Quarter Ever Didn’t Come With a R...

wcc
Jul 28, 2026
0
1
1 Popular Cryptocurrency to Buy Before It Soars 13,000%, According to Bitmine's Tom Lee

1 Popular Cryptocurrency to Buy Before It Soars 13,0...

wcc
Jul 28, 2026
0
1

Supreme Court approval hits record low as Republican...

wcc
Jul 28, 2026
0
1
argenx signs agreement to buy Forte Biosciences for $2.2bn

argenx signs agreement to buy Forte Biosciences for ...

wcc
Jul 28, 2026
0
2
Standard Chartered: Oil Markets Must Now Price Two Middle East Chokepoints

Standard Chartered: Oil Markets Must Now Price Two M...

wcc
Jul 28, 2026
0
1
Is now a good time to get a VA loan?

Is now a good time to get a VA loan?

wcc
Jul 28, 2026
0
1

Comments (0)

User